It cites the description given by the National Pharmaceutical Association for the suggested reclassification of Calpol Six Plus sugar-free suspension as anomalous, unnecessary, and unsafe. It also indicates that the availability of multidose bottle as GSL might provide unwarranted risks to patient ...
It cites the description given by the National Pharmaceutical Association for the suggested reclassification of Calpol Six Plus sugar-free suspension as anomalous, unnecessary, and unsafe. It also indicates that the availability of multidose bottle as GSL might provide unwarranted risks to patient ...